Stockscreener 앱 받기
2.30
8.49%
0.18
시간 외 거래:
2.26
-0.04
-1.74%
Heartbeam Inc 주식(BEAT)의 최신 뉴스
HeartBeam Shares Skyrocket: FDA Boost - timothysykes.com
HeartBeam Soars with FDA Approval for Breakthrough ECG Technology - timothysykes.com
HeartBeam Stock Soars: Should You Buy? - timothysykes.com
Heartbeam stock is a buy, this analyst says - Cantech Letter
Benchmark Upgrades HeartBeam (BEAT) - Nasdaq
HeartBeam Stock Surges: Analyzing the Uptrend - StocksToTrade
Why Is Micro Cap HeartBeam Stock Surging On Wednesday? - Sahm
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
HeartBeam swells on turning FDA rejection into ECG clearance - Fierce Biotech
3 Penny Stocks to Watch Now, 12/11/25 - TipRanks
HeartBeam receives US FDA clearance for at-home arrhythmia assessment with cable-free 12-lead ECG - Cardiac Rhythm News
HeartBeam (BEAT) Receives Upgrade from Benchmark Analyst | BEAT Stock News - GuruFocus
HeartBeam go-to-market strategy remains on track, says Benchmark - TipRanks
HeartBeam stock soars as H.C. Wainwright doubles price target on FDA clearance - Investing.com India
HeartBeam sinks after ‘Not Substantially Equivalent’ letter from FDA - MSN
BEAT Secures FDA Nod for First Cable-Free At-Home 12-Lead ECG System - Nasdaq
HeartBeam Receives FDA Clearance for 12-Lead ECG Synthesis Software Following Appeal - citybuzz
HeartBeam announces FDA clearance for 12-lead ECG synthesis software - MSN
Oracle, Synopsys, Heartbeam, Planet Labs And Adobe: Why These 5 Stocks Are On Investors' Radars Today - Benzinga
Heartbeam Inc. (BEAT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
HC Wainwright & Co. Maintains HeartBeam (BEAT) Buy Recommendation - Nasdaq
Heartbeam wins appeal, gains FDA clearance - BioWorld MedTech
FDA Greenlight Sends HeartBeam, Photronics, And Designer Brands Shares Climbing - Finimize
HeartBeam (BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal - Yahoo Finance
HeartBeam’s Leap: Should Investors Be Wary? - StocksToTrade
FDA Clears HeartBeam Cable-free 12-lead ECG - respiratory-therapy.com
HeartBeam Secures FDA Clearance for 12-Lead ECG Synthesis Software Following Appeal - citybuzz
HeartBeam (BEAT) Stock: Surges 50% After FDA Grants Clearance For its 12-lead ECG Device - parameter.io
HeartBeam (BEAT) Analyst Rating: HC Wainwright Raises Price Targ - GuruFocus
HeartBeam price target raised to $5.50 from $2.50 at H.C. Wainwright - TipRanks
FDA clears HeartBeam’s at-home arrhythmia assessment tool - Yahoo
Weekly Trades: Is HeartBeam Inc stock recession proofTrade Entry Report & Community Trade Idea Sharing Platform - BỘ NỘI VỤ
HeartBeam Receives FDA Clearance for 12-Lead ECG for At-Home Arrhythmia Assessment - marketscreener.com
HeartBeam (NASDAQ: BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal - TradingView
HeartBeam Wins FDA Nod for Cable-Free 12-Lead ECG for Home Arrhythmia Assessment - Medical Product Outsourcing
HeartBeam shares skyrocket after FDA signs off on 12-lead ECG synthesis software - MSN
HeartBeam Shares Surge: Buy Signal? - timothysykes.com
HeartBeam : Earnings Documents - marketscreener.com
HeartBeam stock soars after FDA clearance for 12-lead ECG synthesis software - Investing.com Nigeria
Why Is HeartBeam Stock (BEAT) Up Today? - TipRanks
Heartbeam rises after FDA clears its cable‑free ECG software - TradingView
HeartBeam’s 12-lead ECG synthesis software receives FDA clearance By Investing.com - Investing.com Australia
HeartBeam’s 12-lead ECG synthesis software receives FDA clearance - Investing.com India
HeartBeam earns FDA clearance for first-ever cable-free 12-lead ECG for at-home arrhythmia assessment - MassDevice
Why Did BEAT Stock Rocket 72% In Pre-Market Today? - Stocktwits
Heartbeam, Inc.Common Stock (Nasdaq:BEAT) Stock Quote - Markets Financial Content
HC Wainwright & Co. Initiates Coverage of HeartBeam (BEAT) with Buy Recommendation - Nasdaq
An analyst sees good growth prospects for HeartBeam Inc (BEAT) - Setenews
HeartBeam (BEAT) Receives 'Buy' Rating from HC Wainwright & Co. - GuruFocus
HC Wainwright Initiates HeartBeam at Buy With $2.50 Price Target - marketscreener.com
HeartBeam initiated with a Buy at H.C. Wainwright - TipRanks
Will HeartBeam Inc stock deliver shareholder valueWeekly Investment Report & Stepwise Entry/Exit Trade Alerts - BỘ NỘI VỤ
How institutional buying supports HeartBeam Inc. stockEarnings Risk Summary & Daily Technical Forecast Reports - Newser
Why hedge funds are buying HeartBeam Inc. stockEarnings Miss & Technical Entry and Exit Alerts - Newser
Will HeartBeam Inc. stock maintain dividend yieldMarket Rally & Fast Exit Strategy with Risk Control - Newser
What is the fair value of HeartBeam Inc. Equity Warrant stock nowQuarterly Trade Summary & Advanced Swing Trade Entry Alerts - Newser
HeartBeam Pursues Regulatory Path After FDA Decision on ECG Software - citybuzz
HeartBeam (NASDAQ: BEAT) Outlines Regulatory Strategy After NSE Decision on ECG Synthesis Software - Digital Journal
HeartBeam (BEAT) Outlines Regulatory Strategy After NSE Decision on ECG Synthesis Software - NewMediaWire
HeartBeam Outlines Regulatory Strategy Following FDA Decision on ECG Software - citybuzz
1.32%
6.60%
자본화:
|
볼륨(24시간):